Literature DB >> 12084349

Intravascular lymphomatosis presenting with a conus medullaris syndrome mimicking disseminated encephalomyelitis.

Stefan Schwarz1, Saida Zoubaa, Michael Knauth, Clemens Sommer, Brigitte Storch-Hagenlocher.   

Abstract

We describe the clinical, radiologic, and postmortem findings of a 42-year-old man with intravascular lymphomatosis. The patient presented with a conus medullaris syndrome followed by progressive, disseminated spinal and cerebral symptoms. Disseminated encephalomyelitis was suspected due to the clinical, radiologic, and cerebrospinal fluid findings and the results of a stereotactic brain biopsy, all of which were compatible with inflammatory CNS disease. Treatment with methylprednisolone and cyclophosphamide led to a temporary remission of symptoms. The patient died 13 months after onset of symptoms. The diagnosis of disseminated intravascular lymphomatosis was established after death.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12084349      PMCID: PMC1920637          DOI: 10.1093/neuonc/4.3.187

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  4 in total

1.  Neurological misdiagnoses of lymphoma.

Authors:  Chen Makranz; David Arkadir; Boaz Nachmias; Moshe E Gatt; Ruth Eliahou; Karine Atlan; Anat Mordechai; Netta Goldshmit; Alexander Lossos
Journal:  Neurol Sci       Date:  2020-09-24       Impact factor: 3.307

2.  Nomograms Predict Survival Outcome of Primary Intramedullary Spinal Cord Lymphoma Patients.

Authors:  Qiong Wu; Zuyi Yang; Yuan Xu
Journal:  Med Sci Monit       Date:  2019-10-03

Review 3.  Transverse myelitis.

Authors:  Shin C Beh; Benjamin M Greenberg; Teresa Frohman; Elliot M Frohman
Journal:  Neurol Clin       Date:  2013-02       Impact factor: 3.806

4.  Long Spinal Cord Lesions Caused by Venous Congestive Myelopathy Associated with Intravascular Large B-cell Lymphoma.

Authors:  Takeshi Miura; Shoji Saito; Rie Saito; Tomohiro Iwasaki; Naomi Mezaki; Tomoe Sato; Yoichi Ajioka; Akiyoshi Kakita; Takuya Mashima
Journal:  Intern Med       Date:  2021-06-19       Impact factor: 1.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.